Organization
Kitakyushu Municipal Medical Center
2 abstracts
Abstract
The primary endpoint analysis of SCARLET study: A single-arm, phase II study of sotorasib plus carboplatin-pemetrexed in patients with advanced non-squamous, non-small cell lung cancer with KRAS G12C mutation (WJOG14821L).Org: Kumamoto University Hospital, Kurume University School of Medicine, Kitakyushu Municipal Medical Center, Wakayama Medical University, Wakayama, Japan, Internal Medicine III, Wakayama Medical University,
Abstract
A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017.Org: Okayama University Hospital, Department of Breast Oncology, Peking University Cancer Hospital, The Cancer Institute Hospital of JFCR, Tokyo, Japan, NHO Shikoku Cancer Center, Gunma Cancer Center,